Coloplast AS (LTS:0QBO) Cyclically Adjusted FCF per Share: kr18.17 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QBO Coloplast AS LTS:0QBO
68 GF Score
Price kr430.65
GF Value kr845.38
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Coloplast AS Cyclically Adjusted FCF per Share?

Coloplast AS LTS:0QBO -0.90% 68 Cyclically Adjusted FCF per Share is kr18.17 as of Mar. 2026. GuruFocus rates LTS:0QBO with a GF Score™ of 68/100 and a GF Value™ of kr845.38 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Coloplast AS's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr4.516. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr18.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Coloplast AS's average Cyclically Adjusted FCF Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Coloplast AS was 9.70% per year. The lowest was 1.10% per year. And the median was 7.55% per year.

As of today (2026-08-01), Coloplast AS's current stock price is kr430.65. Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr18.17. Coloplast AS's Cyclically Adjusted Price-to-FCF of today is 23.70.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 20.97. And the median was 53.90.


Coloplast AS  (LTS:0QBO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=430.65/18.17
=23.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 20.97. And the median was 53.90.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Coloplast AS Cyclically Adjusted FCF per Share Related Terms


Coloplast AS Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Cyclically Adjusted FCF per Share Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.59 16.64 16.75 16.18 17.27

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.97 17.07 17.27 17.59 18.17

LTS:0QBO vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted Price-to-FCF falls into.


LTS:0QBO
68GF Score
Coloplast AS LTS:0QBO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.516/121.6800*121.6800
=4.516

Current CPI (Mar. 2026) = 121.6800.

Coloplast AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 2.112 100.600 2.555
201609 5.020 100.200 6.096
201612 0.669 100.300 0.812
201703 0.725 101.200 0.872
201706 4.470 101.200 5.375
201709 6.196 101.800 7.406
201712 3.813 101.300 4.580
201803 1.320 101.700 1.579
201806 5.540 102.300 6.590
201809 6.715 102.400 7.979
201812 3.014 102.100 3.592
201903 1.498 102.900 1.771
201906 5.697 102.900 6.737
201909 7.254 102.900 8.578
201912 3.784 102.900 4.475
202003 1.689 103.300 1.990
202006 5.696 103.200 6.716
202009 6.788 103.500 7.980
202012 -0.085 103.400 -0.100
202103 2.430 104.300 2.835
202106 5.420 105.000 6.281
202109 7.824 105.800 8.998
202112 4.361 106.600 4.978
202203 -0.089 109.900 -0.099
202206 6.182 113.600 6.622
202209 8.189 116.400 8.560
202212 0.998 115.900 1.048
202303 1.874 117.300 1.944
202306 4.128 116.400 4.315
202309 6.662 117.400 6.905
202312 6.735 116.700 7.022
202403 -12.612 118.400 -12.961
202406 5.062 118.500 5.198
202409 7.129 118.900 7.296
202412 7.551 118.900 7.728
202503 1.917 120.200 1.941
202506 5.382 120.700 5.426
202509 8.314 121.600 8.319
202512 8.084 121.200 8.116
202603 4.516 121.680 4.516

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr18.17 mean?
Coloplast AS (LTS:0QBO) has a Cyclically Adjusted FCF per Share of kr18.17 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Coloplast AS and its competitors.
Is Coloplast AS's Cyclically Adjusted FCF per Share too high?
Coloplast AS's current Cyclically Adjusted FCF per Share is kr18.17. Overall, Coloplast AS has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Coloplast AS's Cyclically Adjusted FCF per Share of kr18.17 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Coloplast AS and its competitors. Coloplast AS's current Cyclically Adjusted FCF per Share is kr18.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (LTS:0QBO) is currently considered Significantly Undervalued. The stock's GF Value™ is kr845.38, compared to a current price of kr430.65 — trading 49.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr18.17. Coloplast AS's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Coloplast AS (LTS:0QBO), the current Cyclically Adjusted FCF per Share is kr18.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (LTS:0QBO) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of kr430.65 is trading 49.1% below its estimated GF Value™ of kr845.38. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for LTS:0QBO:

  • Cyclically Adjusted FCF per Share: kr18.17
  • GF Value™: kr845.38 vs. price of kr430.65 (49.1% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the LTS:0QBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
68GF Score

Get the complete analysis for LTS:0QBO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr430.65
Price
kr845.38
GF Value